Saudi Health Authority adopts the AstraZeneca and Moderna vaccines after Pfizer

The Saudi Ministry of Health announced the approval of the AstraZeneca and Moderna vaccines against Coronavirus, after the Pfizer – BioNTech vaccine that was approved earlier in the Kingdom.

The Director of Health in the Eastern Province, Dr. Ibrahim Al-Arifi, said that the approved vaccines are Pfizer – BioNTech, AstraZeneca and Moderna, explaining that the competition is global for vaccines, and there is a great demand for the Pfizer vaccine, but there are good quantities that will arrive in Saudi Arabia for vaccination.

He discussed the increase in the number of workers in vaccine distribution centers in Saudi Arabia, and that they gained good experience, so the work cycle became faster and larger with the expansion of the reception halls of the vaccine recipient.

Furthermore, he revealed that the Al-Ahsa Center for vaccination is ready and waiting for the vaccines to arrive in light of global competition for them. In addition he added that we will start within a week or two while work is underway to equip the Hafar Al-Batin Center, which is expected to operate from next month.

He added that the number of registered people in the “My Health” application in the Eastern Province reached about 400,000 people, while about 60,000 people received the vaccine.

It is noteworthy that the number of registered people in the “My Health” application to receive the vaccine in the Kingdom exceeded two million people, in the first month of the start of the distribution of the vaccines.

According to last month’s statistics, the Saudi Ministry of Health receives 100,000 doses of the Pfizer BioNTech vaccine per week.

The Ministry plans to reach 80% of community immunity, while the vaccination campaign continues in Saudi Arabia with the Pfizer vaccine, awaiting the arrival of quantities of other vaccines and more doses of the Pfizer vaccine.